Cash Flow Statement
Growth Metrics

Lifecore Biomedical, Inc. \De\ (LFCR) Loans and Notes Receivables (2025)

Lifecore Biomedical, Inc. \De\ has reported Loans and Notes Receivables over the past 3 years, most recently at $8.0 million for Q2 2025.

  • For Q2 2025, Loans and Notes Receivables changed N/A year-over-year to $8.0 million; the TTM value through May 2025 reached $8.0 million, changed N/A, while the annual FY2025 figure was $8.0 million, N/A changed from the prior year.
  • Loans and Notes Receivables for Q2 2025 was $8.0 million at Lifecore Biomedical, Inc. \De\, roughly flat from $8.0 million in the prior quarter.
  • Over five years, Loans and Notes Receivables peaked at $8.0 million in Q1 2025 and troughed at $8.0 million in Q1 2025.